LoginSignup
Heidelberg Pharm logo

Heidelberg Pharm Stock

StockStock
ISIN: DE000A11QVV0
Ticker: HPHA
DE000A11QVV0
HPHA

Price

Frequently asked questions

What is Heidelberg Pharm's market capitalization?

The market capitalization of Heidelberg Pharm is $111.82M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Heidelberg Pharm?

Heidelberg Pharm's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.436. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Heidelberg Pharm's stock?

Currently, 2 analysts cover Heidelberg Pharm's stock, with a consensus target price of $12.00. Analyst ratings provide insights into the stock's expected performance.

What is Heidelberg Pharm's revenue over the trailing twelve months?

Over the trailing twelve months, Heidelberg Pharm reported a revenue of $8.99M.

What is the EBITDA for Heidelberg Pharm?

Heidelberg Pharm's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$20.68M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Heidelberg Pharm?

Heidelberg Pharm has a free cash flow of -$32.14M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Heidelberg Pharm's stock?

The 5-year beta for Heidelberg Pharm is -0.84. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Heidelberg Pharm have, and what sector and industry does it belong to?

Heidelberg Pharm employs approximately 98 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Heidelberg Pharm's shares?

The free float of Heidelberg Pharm is 9.03M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $111.82M

5Y beta

 -0.84

EPS (TTM)

 -$0.436

Free Float

 9.03M

Revenue (TTM)

 $8.99M

EBITDA (TTM)

 -$20.68M

Free Cashflow (TTM)

 -$32.14M

Pricing

1D span
$2.355$2.619
52W span
$2.335$4.458

Analyst Ratings

The price target is $12.00 and the stock is covered by 2 analysts.

Buy

2

Hold

0

Sell

0

Information

Heidelberg Pharma AG, formerly Wilex AG, is a Germany-based Company, which is engaged in the biopharmaceuticals sector. The Company focuses on the research and development of therapy treatments for oncology area. It aims at applying toxin Amanitin into cancer therapies using its Antibody Targeted Amanitin Conjugate (ATAC) technology. The Company’s pipeline includes a number of drug candidates, such as HDP-101, a B-cell maturation antigen ATAC for multiple myeloma; PSMA-ATAC, prostate-specific membrane antigens, and CD19-ATAC, a B-lymphocyte antigen. Through partnerships, the Company develops clinical assets, including MESUPRON, REDECTANE and RENCAREX. It also offers preclinical contract research services.

98

Biotechnology & Drugs

Health Care

Identifier

ISIN

DE000A11QVV0

Primary Ticker

HPHA

Knockouts

Join the conversation
Sign upLogin